harmacare
Research Paper
Value in Primary Care: Evidence from the Canadian Primary Care Sentinel Surveillance Network
Sabrina T. Wong, Rachael Morkem, Ayat Salman, David Barber and Jerome A. Leis
Discussion and Debate
Multinational Pharmaceutical Companies Shortchange Canada in Research and Development Investments: Is It Time to Pursue Other Options?
Shoo K. Lee, Sukhy K. Mahl, Jessica J. Green and Joel Lexchin
Discussion and Debate
Commentary: Reconsidering Pharmaceutical Research and Development Investments
Marc-André Gagnon
Research Paper
Pharmacist Disciplinary Action: What Do Pharmacists Get in Trouble for?
Ai-Leng Foong-Reichert, Kelly A. Grindrod, David J. Edwards, Zubin Austin and Sherilyn K.D. Houle
ICES Report
The Impact of Sex and Gender on Prescribing Cascades in Older Adults
Paula Rochon, Misty Pratt and Razan Rawdat
CIHI Survey
Overuse of Tests and Treatments: Has Canada Made Progress?
Alicia Costante, Xi-Kuan Chen, Alexey Dudevich, Antony Dennis Christy, Lyricy Francis and Cheryl Chu...
Invited Paper
Expensive Drugs for Rare Diseases in Canada: What Value and At What Cost?
Sandra Sirrs, Helen Anderson, Bashir Jiwani, Larry D. Lynd, Eric Lun, Bob Nakagawa, Dean Regier, Shi...
Commentary
Specific, Fair and Transparent: A Canadian Process for Funding Drugs for Rare Diseases
Helen Stevenson